SEATTLE — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that dosing has been initiated… Read More
Collaboration combines Engitix’s unique human extracellular matrix (ECM) platform with Takeda’s expertise in gastroenterology research and development (R&D) and commercialisation Agreement with Takeda for the discovery and development of novel… Read More
Toronto, ON —This week marks the 37th annual National Medical Laboratory Week in Canada. Organized by the Canadian Society for Medical Laboratory Science, it celebrates the important professionals who work in the… Read More
AbbVie and MBC BioLabs announce Qinotto and Think Bioscience as the winners of their 2022 Golden Ticket Competition. The award supports entrepreneurial scientists and emerging biotechnology start-ups to accelerate early drug discovery and innovation… Read More
Long-Term Clinical Benefit and Prolonged Tumor Response Seen With 40.7% Objective Response Rate No New Safety Signals Observed Longest Follow-Up of Patients Treated With a KRASG12C Inhibitor THOUSAND OAKS, CA –– Amgen (NASDAQ:… Read More
